Cancer chemotherapy and pharmacology, 2024-05, Vol.93 (5), p.519-521
2024
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Pharmacokinetic drug–drug interaction between olaparib and apixaban: a case report
- Ist Teil von
- Cancer chemotherapy and pharmacology, 2024-05, Vol.93 (5), p.519-521
- Ort / Verlag
- Berlin/Heidelberg: Springer Berlin Heidelberg
- Erscheinungsjahr
- 2024
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0344-5704eISSN: 1432-0843DOI: 10.1007/s00280-023-04606-8Titel-ID: cdi_proquest_journals_3046677028
- Format
- –
- Schlagworte
- Cancer Research, Drug interaction, Drug Interactions, Factor Xa Inhibitors - adverse effects, Factor Xa Inhibitors - pharmacokinetics, Humans, Letter to the Editor, Medicine, Medicine & Public Health, Oncology, Pharmacokinetics, Pharmacology/Toxicology, Phthalazines - adverse effects, Phthalazines - pharmacokinetics, Piperazines - administration & dosage, Piperazines - adverse effects, Piperazines - pharmacokinetics, Poly(ADP-ribose) Polymerase Inhibitors - adverse effects, Poly(ADP-ribose) Polymerase Inhibitors - pharmacokinetics, Pyrazoles - adverse effects, Pyrazoles - pharmacokinetics, Pyridones - administration & dosage, Pyridones - adverse effects, Pyridones - pharmacokinetics